Exozymes (EXOZ) Cash & Current Investments (2023 - 2026)

Exozymes (EXOZ) has reported Cash & Current Investments for 3 consecutive years, with $3.0 million the latest figure, recorded in Q4 2025.

• In Q4 2025, Cash & Current Investments fell 68.73% year-over-year to $3.0 million; the TTM figure through Dec 2025 stood at $3.0 million (down 68.73% YoY), while the FY2025 annual figure was $3.0 million, down 68.73% from the prior year.
• Cash & Current Investments eased to $3.0 million in Q4 2025 per EXOZ's latest filing, from $5.1 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $9.7 million in Q4 2024 and bottomed at $66533.0 in Q4 2023.
• Historically, Cash & Current Investments has averaged $4.8 million across 3 years, with a median of $5.1 million in 2025.
• Annual changes were most pronounced in 2024 — Cash & Current Investments jumped 14508.25% — and 2025, when it sank 68.73%.
• Exozymes' Cash & Current Investments stood at $66533.0 in 2023, then surged by 14508.25% to $9.7 million in 2024, then tumbled by 68.73% to $3.0 million in 2025.
• Business Quant data shows EXOZ's Cash & Current Investments at $3.0 million in Q4 2025, $5.1 million in Q3 2025, and $7.0 million in Q2 2025.